Jared Fischer | Nanotechnology | Best Researcher Award

Published on by Chemical Scientist

Dr. Jared Fischer | Nanotechnology | Best Researcher Award

Assistant Professor at Oregon Health and Science University , United States.

Dr. Jared Fischer 🧬 is an Assistant Professor at the Oregon Health & Science University (OHSU) in the Department of Molecular and Medical Genetics/CEDAR πŸ§‘β€πŸ«. With a dual degree in Zoology and Chemistry πŸ§ͺ from Miami University and a PhD in Molecular Genetics 🧫 from the University of Cincinnati, he has cultivated a rich career in cancer biology, senescence, and in vivo imaging. His innovative work in nanomedicine, cancer detection, and senolytic therapies has led to numerous high-impact publications and grants. Dr. Fischer is not only a prolific researcher πŸ“š but also a committed educator and mentor to future scientists πŸ‘¨β€πŸ”¬.

PROFILEΒ 

GOOGLE SCHOLARΒ 

SCOPUSΒ 

ORCIDΒ 

πŸ” Summary of Suitability:

Dr. Jared Fischer is an outstanding biomedical scientist and faculty member at Oregon Health & Science University (OHSU), serving as Assistant Professor in the Department of Molecular and Medical Genetics/CEDAR. His research career exemplifies consistent innovation, high-impact scholarship, and a commitment to translational medicine. His work spans multiple disciplines, including molecular genetics, cancer biology, nanomedicine, and biomedical imaging. Dr. Fischer has secured prestigious federal and institutional grants and consistently publishes in top-tier journals. Moreover, he has demonstrated exemplary service through education, mentorship, and committee leadershipβ€”solidifying his role as a leader and innovator in the research community.

πŸŽ“ Education and Experience

πŸŽ“ Education:

  • πŸ§ͺ BS in Zoology & BA in Chemistry, Miami University (1999–2003)

  • 🧬 PhD in Molecular Genetics, University of Cincinnati (2003–2008)

  • πŸ”¬ Postdoctoral Fellowship in Molecular and Medical Genetics, OHSU (2009–2017)

🏒 Academic Experience:

  • πŸ‘¨β€πŸ« Assistant Professor, OHSU, Molecular & Medical Genetics (2017–Present)

Professional Development πŸš€πŸ“–

Dr. Fischer’s professional growth is rooted in continuous learning, leadership, and service πŸ“ˆ. He completed the Leadership Development Course from Brave Heart Consulting in 2024 🧠 and was certified by the Mentorship Academy in 2023. Actively involved in mentoring underrepresented students πŸ‘¨β€πŸŽ“, he has contributed to cancer education through programs like the CURE Program and the Partnership for Scientific Inquiry πŸ”. As IACUC vice-chair and editorial reviewer ✍️, his institutional service has significantly impacted research governance and publication. His commitment to advancing scientific education, ethics, and community health underscores his dynamic and evolving career 🎯.

Research Focus πŸ”πŸ€–

Dr. Fischer’s research centers on cancer biology 🧫, senescence πŸ§“, and molecular imaging 🧲, particularly through nanomedicine and bioengineering innovations. His work targets early cancer detection πŸ§β€βš•οΈ, tumor progression 🧬, and therapeutic development using multifunctional nanomaterials and senolytic peptides πŸ’Š. He is known for pioneering diagnostic assays and nanoparticle-based imaging techniques πŸ§ͺ, as demonstrated in his recent publications on pancreatic and colorectal cancers. His interdisciplinary focus bridges molecular genetics, biomedical imaging, and computational modeling 🧠, aligning with cutting-edge research in oncology and personalized medicine πŸ§‘β€βš•οΈ. His contributions are shaping next-generation strategies in precision diagnostics and therapeutic delivery πŸš€.

Awards and Honors πŸ†πŸŽ–οΈ

  • 🧾 OHSU β€œPaper of the Month” for PNAS publication, December 2016

  • πŸ§‘β€πŸŽ“ Graduate Student of the Year, University of Cincinnati, Department of Molecular Genetics, 2008

  • 🎀 Invited Speaker at Cambridge University, Cold Spring Harbor, and various ACS events

  • πŸŽ—οΈ Recognized across high-profile media (Nature, Science News, Forbes, JAMA) for breakthrough cancer diagnostics research

Publications & Citations πŸ“š

πŸ“˜ 2025

  • 🧬 Early detection of pancreatic cancer by protease-activated nanosensor assay – Published in Science Translational Medicine, featured in Nature, Science News, Forbes πŸ“ˆ

πŸ“— 2024

  • πŸ§ͺ Profiling protease cleavage in plasma for pancreatic cancer – Published in Scientific Reports

  • 🧫 Tumor-immune hybrid cells and colorectal cancer metastasis via CTLA4 – Published in Clinical and Experimental Medicine

πŸ“™ 2023

  • πŸ’‘ Ultrafast ultrasound imaging using blinking nanoparticles – Published in Nano Letters

  • 🧬 Gas-stabilizing nanoparticles for cancer therapy – Published in Advanced Materials Interfaces

πŸ“— 2022

  • βš—οΈ Hybrid PLGA nanoparticles for enzyme therapy – Published in Pharmaceutics

  • πŸ”¬ Computational design of TP63-TP53 inhibitors – Published in Molecular Cancer Therapeutics

πŸ“˜ 2021

  • 🧠 Modeling FOXO4-TP53 to create senolytic peptides – Published in EBioMedicine

  • πŸ” Label-free enrichment of rare neoplastic cells using microfluidics – Published in Communications Biology

πŸ“• 2020

  • πŸ“Š Weight loss, biomarkers & cancer risk – Published in Surg Obes Relat Dis

πŸ“˜ 2019

  • 🧫 Silica cloaking of adenovirus for gene delivery – Published in Journal of Controlled Release

πŸ“™ 2018

  • 🧬 Cell fusion and hybrid circulating tumor cells – Published in Science Advances, highly cited and shared πŸ“ˆ

πŸ“— 2017

  • 🧬 Genetic divergence in tumor evolution – Published in Nature Genetics, highly cited and impactful πŸ“ˆ

πŸ“• 2016

  • 🧬 TgfΞ²R2 in intestinal stem cells – Published in PNAS, earned “Paper of the Month” at OHSU πŸ†

  • πŸ§ͺ Pms2 ATPase domain study – Published in DNA Repair

πŸ“˜ 2014

  • 🧬 Apc-deficient crypts and chemoprevention – Published in Carcinogenesis

πŸ“• 2012

  • 🧬 Phenotypic outcomes of Apc loss – Published in Oncogene

πŸ“™ 2008–2006 (select highlights)

  • 🧬 Mutation in aging mice – Published in Aging Cell

  • πŸ” Loss of heterozygosity in mouse tissues – Published in Mutation Research

  • 🧫 Co-mutagenic effects of arsenic and benzo[a]pyrene – Published in Mutation Research

πŸ“— 2004–2003

  • 🧬 Evolution of Pneumocystis species – Published in Microbiology & J Eukaryotic Microbiology

πŸ” Conclusion:

Dr. Jared Fischer is a truly deserving nominee for the Best Researcher Award. His body of work demonstrates not only scientific rigor and innovation but also a profound impact on patient care, early disease detection, and therapeutic development. His interdisciplinary approach, dedication to mentoring, and consistent scholarly output position him among the top-tier researchers advancing modern medicine today.